Short‐Term Outcomes of a High‐Volume, Low‐Concentration Bolus Starting Dose Technique With Ziconotide: A Case Series

BACKGROUND AND OBJECTIVES: There have been numerous recommendations for a starting dose of intrathecal ziconotide. The therapy remains underutilized partially due to reports of inefficacy and/or intolerance. This study describes short‐term outcomes of a high‐volume, low‐concentration bolus (HVLC‐B)...

Descripción completa

Detalles Bibliográficos
Autor principal: Lindley, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
INTRATHECAL DRUG DELIVERY
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596839/
https://www.ncbi.nlm.nih.gov/pubmed/34252245
http://dx.doi.org/10.1111/ner.13475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596839/
https://www.ncbi.nlm.nih.gov/pubmed/34252245
http://dx.doi.org/10.1111/ner.13475

Ejemplares similares